Your shopping cart is currently empty

PNSC928 is an inhibitor of the CtBP2-p300 interaction, with an IC50 of 23.60 µM. It can reverse the expression of pro-inflammatory cytokines induced by Lipopolysaccharides in RAW264.7 cells. Additionally, PNSC928 has the potential to ameliorate acute respiratory distress syndrome (ARDS) in mice.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PNSC928 is an inhibitor of the CtBP2-p300 interaction, with an IC50 of 23.60 µM. It can reverse the expression of pro-inflammatory cytokines induced by Lipopolysaccharides in RAW264.7 cells. Additionally, PNSC928 has the potential to ameliorate acute respiratory distress syndrome (ARDS) in mice. |
| Formula | C25H38O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.